Rank | Gene Set | Z-score |
---|---|---|
1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.36204306 |
2 | L-phenylalanine catabolic process (GO:0006559) | 7.36204306 |
3 | L-phenylalanine metabolic process (GO:0006558) | 7.00273323 |
4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.00273323 |
5 | aromatic amino acid family catabolic process (GO:0009074) | 6.65083321 |
6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.45211714 |
7 | exogenous drug catabolic process (GO:0042738) | 6.39912803 |
8 | tryptophan catabolic process (GO:0006569) | 6.02347610 |
9 | indole-containing compound catabolic process (GO:0042436) | 6.02347610 |
10 | indolalkylamine catabolic process (GO:0046218) | 6.02347610 |
11 | bile acid biosynthetic process (GO:0006699) | 5.96449318 |
12 | kynurenine metabolic process (GO:0070189) | 5.89435158 |
13 | tryptophan metabolic process (GO:0006568) | 5.66670817 |
14 | high-density lipoprotein particle remodeling (GO:0034375) | 5.62682012 |
15 | glyoxylate metabolic process (GO:0046487) | 5.60283284 |
16 | urea metabolic process (GO:0019627) | 5.52055758 |
17 | urea cycle (GO:0000050) | 5.52055758 |
18 | alpha-linolenic acid metabolic process (GO:0036109) | 5.47766627 |
19 | negative regulation of fibrinolysis (GO:0051918) | 5.41180680 |
20 | cysteine metabolic process (GO:0006534) | 5.35223838 |
21 | epoxygenase P450 pathway (GO:0019373) | 5.34760125 |
22 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.34708857 |
23 | protein carboxylation (GO:0018214) | 5.34708857 |
24 | response to mercury ion (GO:0046689) | 5.31760398 |
25 | regulation of fibrinolysis (GO:0051917) | 5.30165181 |
26 | sulfur amino acid catabolic process (GO:0000098) | 5.26148116 |
27 | regulation of protein activation cascade (GO:2000257) | 5.18826792 |
28 | complement activation, alternative pathway (GO:0006957) | 5.16017433 |
29 | serine family amino acid catabolic process (GO:0009071) | 5.11776115 |
30 | omega-hydroxylase P450 pathway (GO:0097267) | 5.10051879 |
31 | bile acid metabolic process (GO:0008206) | 5.08315542 |
32 | nitrogen cycle metabolic process (GO:0071941) | 5.06202534 |
33 | regulation of cholesterol esterification (GO:0010872) | 4.96396357 |
34 | regulation of triglyceride catabolic process (GO:0010896) | 4.94198788 |
35 | reverse cholesterol transport (GO:0043691) | 4.89612748 |
36 | plasma lipoprotein particle remodeling (GO:0034369) | 4.86557642 |
37 | protein-lipid complex remodeling (GO:0034368) | 4.86557642 |
38 | macromolecular complex remodeling (GO:0034367) | 4.86557642 |
39 | regulation of complement activation (GO:0030449) | 4.85523120 |
40 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.81060248 |
41 | aromatic amino acid family metabolic process (GO:0009072) | 4.80478490 |
42 | phospholipid efflux (GO:0033700) | 4.78576976 |
43 | homocysteine metabolic process (GO:0050667) | 4.71036797 |
44 | tyrosine metabolic process (GO:0006570) | 4.64329062 |
45 | negative regulation of sterol transport (GO:0032372) | 4.59715759 |
46 | negative regulation of cholesterol transport (GO:0032375) | 4.59715759 |
47 | acylglycerol homeostasis (GO:0055090) | 4.58592058 |
48 | triglyceride homeostasis (GO:0070328) | 4.58592058 |
49 | alpha-amino acid catabolic process (GO:1901606) | 4.56821842 |
50 | * amino-acid betaine metabolic process (GO:0006577) | 4.56806872 |
51 | bile acid and bile salt transport (GO:0015721) | 4.36746511 |
52 | lysine metabolic process (GO:0006553) | 4.36605041 |
53 | lysine catabolic process (GO:0006554) | 4.36605041 |
54 | glycine metabolic process (GO:0006544) | 4.35635008 |
55 | cellular glucuronidation (GO:0052695) | 4.34027462 |
56 | cellular ketone body metabolic process (GO:0046950) | 4.33211151 |
57 | imidazole-containing compound metabolic process (GO:0052803) | 4.32479823 |
58 | plasma lipoprotein particle clearance (GO:0034381) | 4.30969666 |
59 | ethanol oxidation (GO:0006069) | 4.27360395 |
60 | cellular biogenic amine catabolic process (GO:0042402) | 4.27215346 |
61 | amine catabolic process (GO:0009310) | 4.27215346 |
62 | coenzyme catabolic process (GO:0009109) | 4.26532621 |
63 | indolalkylamine metabolic process (GO:0006586) | 4.25754653 |
64 | drug metabolic process (GO:0017144) | 4.25106038 |
65 | cholesterol efflux (GO:0033344) | 4.22776513 |
66 | low-density lipoprotein particle remodeling (GO:0034374) | 4.20909032 |
67 | cellular amino acid catabolic process (GO:0009063) | 4.19432475 |
68 | fibrinolysis (GO:0042730) | 4.16369877 |
69 | glutamate metabolic process (GO:0006536) | 4.13051152 |
70 | serine family amino acid metabolic process (GO:0009069) | 4.12082522 |
71 | negative regulation of lipase activity (GO:0060192) | 4.06106112 |
72 | benzene-containing compound metabolic process (GO:0042537) | 4.03411203 |
73 | cellular modified amino acid catabolic process (GO:0042219) | 4.01183438 |
74 | ethanol metabolic process (GO:0006067) | 3.99217745 |
75 | plasma lipoprotein particle assembly (GO:0034377) | 3.95432656 |
76 | arginine metabolic process (GO:0006525) | 3.92314431 |
77 | drug catabolic process (GO:0042737) | 3.90959799 |
78 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.87559798 |
79 | oxidative demethylation (GO:0070989) | 3.86522144 |
80 | uronic acid metabolic process (GO:0006063) | 3.84994532 |
81 | glucuronate metabolic process (GO:0019585) | 3.84994532 |
82 | positive regulation of lipid catabolic process (GO:0050996) | 3.81196422 |
83 | blood coagulation, intrinsic pathway (GO:0007597) | 3.78886485 |
84 | serine family amino acid biosynthetic process (GO:0009070) | 3.76124945 |
85 | short-chain fatty acid metabolic process (GO:0046459) | 3.75841987 |
86 | aldehyde catabolic process (GO:0046185) | 3.75320386 |
87 | ketone body metabolic process (GO:1902224) | 3.74663830 |
88 | cholesterol homeostasis (GO:0042632) | 3.73765047 |
89 | regulation of bile acid biosynthetic process (GO:0070857) | 3.73329209 |
90 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.72156266 |
91 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.72156266 |
92 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.70905069 |
93 | phenylpropanoid metabolic process (GO:0009698) | 3.70712899 |
94 | protein activation cascade (GO:0072376) | 3.69225646 |
95 | organic acid catabolic process (GO:0016054) | 3.68913958 |
96 | carboxylic acid catabolic process (GO:0046395) | 3.68913958 |
97 | S-adenosylmethionine metabolic process (GO:0046500) | 3.68243060 |
98 | sterol homeostasis (GO:0055092) | 3.67060779 |
99 | complement activation, classical pathway (GO:0006958) | 3.66546294 |
100 | plasma lipoprotein particle organization (GO:0071827) | 3.65718986 |
101 | complement activation (GO:0006956) | 3.65210682 |
102 | cofactor catabolic process (GO:0051187) | 3.64439880 |
103 | phospholipid homeostasis (GO:0055091) | 3.62646985 |
104 | regulation of cholesterol homeostasis (GO:2000188) | 3.62225945 |
105 | acetyl-CoA metabolic process (GO:0006084) | 3.60523206 |
106 | axon ensheathment in central nervous system (GO:0032291) | 3.53690577 |
107 | central nervous system myelination (GO:0022010) | 3.53690577 |
108 | cytolysis (GO:0019835) | 3.53148918 |
109 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.51913700 |
110 | protein-lipid complex assembly (GO:0065005) | 3.49743303 |
111 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.46654836 |
112 | flavonoid metabolic process (GO:0009812) | 3.46584077 |
113 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.44199356 |
114 | primary alcohol catabolic process (GO:0034310) | 3.39950760 |
115 | negative regulation of blood coagulation (GO:0030195) | 3.27312786 |
116 | negative regulation of hemostasis (GO:1900047) | 3.27312786 |
117 | L-methionine salvage (GO:0071267) | 3.22164365 |
118 | L-methionine biosynthetic process (GO:0071265) | 3.22164365 |
119 | amino acid salvage (GO:0043102) | 3.22164365 |
120 | regulation of plasminogen activation (GO:0010755) | 3.21355918 |
121 | sodium-independent organic anion transport (GO:0043252) | 3.09707936 |
122 | opsonization (GO:0008228) | 3.07783291 |
123 | negative regulation of wound healing (GO:0061045) | 2.98171849 |
124 | negative regulation of coagulation (GO:0050819) | 2.97308781 |
125 | response to auditory stimulus (GO:0010996) | 2.94370278 |
126 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.93604509 |
127 | negative regulation of protein activation cascade (GO:2000258) | 2.92083848 |
128 | steroid catabolic process (GO:0006706) | 2.90276680 |
129 | primary alcohol metabolic process (GO:0034308) | 2.86768920 |
130 | alkaloid metabolic process (GO:0009820) | 2.85368238 |
131 | daunorubicin metabolic process (GO:0044597) | 2.85299565 |
132 | polyketide metabolic process (GO:0030638) | 2.85299565 |
133 | doxorubicin metabolic process (GO:0044598) | 2.85299565 |
134 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.81591331 |
135 | monocarboxylic acid catabolic process (GO:0072329) | 2.76250518 |
136 | astrocyte differentiation (GO:0048708) | 2.76105020 |
137 | xenobiotic catabolic process (GO:0042178) | 2.74569593 |
138 | xenobiotic metabolic process (GO:0006805) | 2.74133574 |
139 | heme transport (GO:0015886) | 2.72573678 |
140 | negative regulation of complement activation (GO:0045916) | 2.69532493 |
141 | postsynaptic membrane organization (GO:0001941) | 2.69363584 |
142 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.67492437 |
143 | L-amino acid import (GO:0043092) | 2.67175898 |
144 | very long-chain fatty acid metabolic process (GO:0000038) | 2.64757868 |
Rank | Gene Set | Z-score |
---|---|---|
1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.95544777 |
2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.85787276 |
3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.78741673 |
4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.20688636 |
5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.11949160 |
6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.70688269 |
7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.58933751 |
8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.82068545 |
9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.57135606 |
10 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.85033137 |
11 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.70450302 |
12 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.32707947 |
13 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.07227192 |
14 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.3603706 |
15 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.93536205 |
16 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.88663478 |
17 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.87991479 |
18 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.82513570 |
19 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.69681338 |
20 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.64111695 |
21 | GATA1_22025678_ChIP-Seq_K562_Human | 1.61126913 |
22 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.60656474 |
23 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.59318943 |
24 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.59158385 |
25 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.54115444 |
26 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.48020218 |
27 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.45454120 |
28 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.44861234 |
29 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.40498753 |
30 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.38259962 |
31 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.35963198 |
32 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.35538067 |
33 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.32782404 |
34 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.31817529 |
35 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.30719789 |
36 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.29743556 |
37 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.29604786 |
38 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.26405443 |
39 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.26405443 |
40 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.25989993 |
41 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.25966049 |
42 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.24758928 |
43 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.23295897 |
44 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.19964951 |
45 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.19448536 |
46 | * EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.19102638 |
47 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.17054850 |
48 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.16770139 |
49 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.16627401 |
50 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.15378577 |
51 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.12211406 |
52 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.11873697 |
53 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.10131529 |
54 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.06550935 |
55 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.06275698 |
56 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.06244551 |
57 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.05928960 |
58 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.05653346 |
59 | TP53_16413492_ChIP-PET_HCT116_Human | 1.05484873 |
60 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.04205054 |
61 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.04120307 |
62 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.02645761 |
63 | P300_19829295_ChIP-Seq_ESCs_Human | 1.02396307 |
64 | CJUN_26792858_Chip-Seq_BT549_Human | 1.01930761 |
65 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.01551758 |
66 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.00163582 |
67 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.98369348 |
68 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.98359467 |
69 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.97810199 |
70 | STAT3_23295773_ChIP-Seq_U87_Human | 0.97587345 |
71 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.97428924 |
72 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.96952796 |
73 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.96602157 |
74 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.96391671 |
75 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.95815293 |
76 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.94778500 |
77 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.94692649 |
78 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.94137160 |
79 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.93822684 |
80 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.93431248 |
81 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.92735687 |
82 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.92555530 |
83 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.91174377 |
84 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.91159633 |
85 | * AR_25329375_ChIP-Seq_VCAP_Human | 0.89555645 |
86 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.88596736 |
87 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.88508862 |
88 | * P53_22387025_ChIP-Seq_ESCs_Mouse | 0.88415047 |
89 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.88179875 |
90 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.87764656 |
91 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.87046978 |
92 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.86770246 |
93 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.86740996 |
94 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.86522961 |
95 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.86281727 |
96 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.86274110 |
97 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.86147418 |
98 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.85293958 |
99 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.85042490 |
100 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.84810565 |
101 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.84677625 |
102 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.84630111 |
103 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.82723218 |
104 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.81779642 |
105 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.81288381 |
106 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.80061275 |
107 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.80061275 |
108 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.78581176 |
109 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.77939277 |
110 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.74309282 |
111 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.73507604 |
112 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.72808605 |
113 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.72120845 |
114 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.69827297 |
115 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.68678845 |
116 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.67737799 |
117 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.67422052 |
118 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.67025294 |
119 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.64053534 |
120 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.62880699 |
121 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.59131234 |
122 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.58427596 |
123 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.58310672 |
124 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.57963958 |
125 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.57578095 |
126 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.57401590 |
127 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.56812613 |
128 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.55897684 |
129 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.55466958 |
130 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.54925587 |
131 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.54384580 |
132 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.54068810 |
133 | * AR_20517297_ChIP-Seq_VCAP_Human | 0.53352545 |
134 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.53322992 |
135 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.52701571 |
136 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.52262680 |
137 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.51021579 |
138 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.50427148 |
139 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.49893973 |
140 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.49641227 |
141 | * MYC_19915707_ChIP-ChIP_AK7_Human | 0.49487017 |
142 | * CBP_21632823_ChIP-Seq_H3396_Human | 0.49429434 |
143 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.49312764 |
144 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.49170308 |
145 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.47257279 |
146 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.47147342 |
147 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.46980335 |
148 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.46404460 |
149 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.46250413 |
150 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.45503837 |
151 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.45467804 |
152 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.44886540 |
153 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.43599424 |
154 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.43555513 |
155 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.43487339 |
156 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.42719884 |
157 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.42537165 |
158 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.42231905 |
159 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.42203134 |
160 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.39759081 |
161 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.39680899 |
162 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.39470010 |
163 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.39020889 |
164 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.38192906 |
165 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.38130856 |
166 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.37860474 |
167 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.37271165 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 8.10044337 |
2 | MP0005360_urolithiasis | 7.32368877 |
3 | MP0005085_abnormal_gallbladder_physiolo | 6.36922709 |
4 | MP0005365_abnormal_bile_salt | 5.99217290 |
5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.06632065 |
6 | MP0003806_abnormal_nucleotide_metabolis | 3.94264218 |
7 | MP0003252_abnormal_bile_duct | 3.80891203 |
8 | MP0010329_abnormal_lipoprotein_level | 3.50447554 |
9 | MP0009840_abnormal_foam_cell | 3.30409903 |
10 | MP0003136_yellow_coat_color | 3.20985445 |
11 | MP0005083_abnormal_biliary_tract | 2.94365411 |
12 | MP0003195_calcinosis | 2.81304227 |
13 | MP0001666_abnormal_nutrient_absorption | 2.64917619 |
14 | MP0005332_abnormal_amino_acid | 2.59296161 |
15 | MP0004043_abnormal_pH_regulation | 2.53519488 |
16 | MP0004885_abnormal_endolymph | 2.27493030 |
17 | MP0005171_absent_coat_pigmentation | 2.25369254 |
18 | MP0004019_abnormal_vitamin_homeostasis | 2.18590616 |
19 | MP0003191_abnormal_cellular_cholesterol | 2.16269508 |
20 | MP0004859_abnormal_synaptic_plasticity | 2.05009856 |
21 | MP0000609_abnormal_liver_physiology | 2.03240156 |
22 | MP0002118_abnormal_lipid_homeostasis | 2.02938371 |
23 | MP0001984_abnormal_olfaction | 1.87199988 |
24 | MP0002638_abnormal_pupillary_reflex | 1.84966493 |
25 | MP0003011_delayed_dark_adaptation | 1.78160911 |
26 | MP0002138_abnormal_hepatobiliary_system | 1.74060248 |
27 | MP0003868_abnormal_feces_composition | 1.73331619 |
28 | MP0005451_abnormal_body_composition | 1.66644192 |
29 | MP0005319_abnormal_enzyme/_coenzyme | 1.63963797 |
30 | MP0002254_reproductive_system_inflammat | 1.62935216 |
31 | MP0001764_abnormal_homeostasis | 1.59091996 |
32 | MP0002796_impaired_skin_barrier | 1.56015194 |
33 | MP0009697_abnormal_copulation | 1.53404951 |
34 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.45298832 |
35 | MP0003879_abnormal_hair_cell | 1.42105013 |
36 | MP0003183_abnormal_peptide_metabolism | 1.40623866 |
37 | MP0003880_abnormal_central_pattern | 1.40059585 |
38 | MP0000920_abnormal_myelination | 1.39899455 |
39 | MP0001486_abnormal_startle_reflex | 1.33778974 |
40 | MP0004270_analgesia | 1.32424594 |
41 | MP0002653_abnormal_ependyma_morphology | 1.30705883 |
42 | MP0005167_abnormal_blood-brain_barrier | 1.29967023 |
43 | MP0005423_abnormal_somatic_nervous | 1.26316605 |
44 | MP0005647_abnormal_sex_gland | 1.26039215 |
45 | MP0004381_abnormal_hair_follicle | 1.23205164 |
46 | MP0002064_seizures | 1.23105537 |
47 | MP0003705_abnormal_hypodermis_morpholog | 1.14727264 |
48 | MP0009643_abnormal_urine_homeostasis | 1.14184021 |
49 | MP0003186_abnormal_redox_activity | 1.12835714 |
50 | MP0003635_abnormal_synaptic_transmissio | 1.12808676 |
51 | MP0003632_abnormal_nervous_system | 1.12572721 |
52 | MP0002282_abnormal_trachea_morphology | 1.12187307 |
53 | MP0001502_abnormal_circadian_rhythm | 1.11702364 |
54 | MP0009764_decreased_sensitivity_to | 1.10669978 |
55 | MP0009745_abnormal_behavioral_response | 1.09608539 |
56 | MP0002063_abnormal_learning/memory/cond | 1.08790841 |
57 | MP0010234_abnormal_vibrissa_follicle | 1.06444841 |
58 | MP0000762_abnormal_tongue_morphology | 1.06197780 |
59 | MP0003656_abnormal_erythrocyte_physiolo | 1.05548134 |
60 | MP0003634_abnormal_glial_cell | 1.05186235 |
61 | MP0000778_abnormal_nervous_system | 1.03405601 |
62 | MP0003633_abnormal_nervous_system | 1.02239352 |
63 | MP0000598_abnormal_liver_morphology | 0.99759230 |
64 | MP0004858_abnormal_nervous_system | 0.98415279 |
65 | MP0002736_abnormal_nociception_after | 0.98154203 |
66 | MP0002876_abnormal_thyroid_physiology | 0.97565952 |
67 | MP0002090_abnormal_vision | 0.96649075 |
68 | MP0002272_abnormal_nervous_system | 0.96008603 |
69 | MP0003941_abnormal_skin_development | 0.95374181 |
70 | MP0000604_amyloidosis | 0.94699790 |
71 | MP0010386_abnormal_urinary_bladder | 0.93567809 |
72 | MP0009763_increased_sensitivity_to | 0.92748493 |
73 | MP0008569_lethality_at_weaning | 0.91235742 |
74 | MP0002572_abnormal_emotion/affect_behav | 0.90905818 |
75 | MP0003631_nervous_system_phenotype | 0.89879792 |
76 | MP0001968_abnormal_touch/_nociception | 0.89623802 |
77 | MP0009384_cardiac_valve_regurgitation | 0.88676376 |
78 | MP0003690_abnormal_glial_cell | 0.85958078 |
79 | MP0005670_abnormal_white_adipose | 0.85520589 |
80 | MP0000026_abnormal_inner_ear | 0.84969696 |
81 | MP0004142_abnormal_muscle_tone | 0.84582452 |
82 | MP0005408_hypopigmentation | 0.84461344 |
83 | MP0005636_abnormal_mineral_homeostasis | 0.83938763 |
84 | MP0005377_hearing/vestibular/ear_phenot | 0.82470959 |
85 | MP0003878_abnormal_ear_physiology | 0.82470959 |
86 | MP0000579_abnormal_nail_morphology | 0.81900735 |
87 | MP0001485_abnormal_pinna_reflex | 0.81068797 |
88 | MP0009642_abnormal_blood_homeostasis | 0.77873297 |
89 | MP0009765_abnormal_xenobiotic_induced | 0.77453274 |
90 | MP0002249_abnormal_larynx_morphology | 0.77246611 |
91 | MP0002734_abnormal_mechanical_nocicepti | 0.77209214 |
92 | MP0008469_abnormal_protein_level | 0.76692010 |
93 | MP0009053_abnormal_anal_canal | 0.76520476 |
94 | MP0002060_abnormal_skin_morphology | 0.76107841 |
95 | MP0001905_abnormal_dopamine_level | 0.75753917 |
96 | MP0001963_abnormal_hearing_physiology | 0.75752654 |
97 | MP0002909_abnormal_adrenal_gland | 0.75328861 |
98 | MP0005551_abnormal_eye_electrophysiolog | 0.75219485 |
99 | MP0010368_abnormal_lymphatic_system | 0.74690150 |
100 | MP0005501_abnormal_skin_physiology | 0.73437279 |
101 | MP0005187_abnormal_penis_morphology | 0.71950508 |
102 | MP0005376_homeostasis/metabolism_phenot | 0.70984935 |
103 | MP0002735_abnormal_chemical_nociception | 0.69131839 |
104 | MP0001177_atelectasis | 0.68141754 |
105 | MP0002971_abnormal_brown_adipose | 0.66444346 |
106 | MP0001270_distended_abdomen | 0.65076765 |
107 | MP0006036_abnormal_mitochondrial_physio | 0.64405194 |
108 | MP0003718_maternal_effect | 0.63838344 |
109 | MP0002078_abnormal_glucose_homeostasis | 0.63755759 |
110 | MP0003453_abnormal_keratinocyte_physiol | 0.63737894 |
111 | MP0004130_abnormal_muscle_cell | 0.62692584 |
112 | MP0001853_heart_inflammation | 0.61759586 |
113 | MP0005334_abnormal_fat_pad | 0.61027599 |
114 | MP0005220_abnormal_exocrine_pancreas | 0.59220475 |
115 | MP0001661_extended_life_span | 0.58789790 |
116 | MP0005535_abnormal_body_temperature | 0.58732900 |
117 | MP0003638_abnormal_response/metabolism_ | 0.58439526 |
118 | MP0004782_abnormal_surfactant_physiolog | 0.57559655 |
119 | MP0003329_amyloid_beta_deposits | 0.57268593 |
120 | MP0005084_abnormal_gallbladder_morpholo | 0.57031526 |
121 | MP0005266_abnormal_metabolism | 0.54117245 |
122 | MP0001216_abnormal_epidermal_layer | 0.53874502 |
123 | MP0000647_abnormal_sebaceous_gland | 0.53353384 |
124 | MP0005395_other_phenotype | 0.53118299 |
125 | MP0009780_abnormal_chondrocyte_physiolo | 0.52610336 |
126 | MP0000639_abnormal_adrenal_gland | 0.51415688 |
127 | MP0001756_abnormal_urination | 0.51346212 |
128 | MP0000427_abnormal_hair_cycle | 0.48771639 |
129 | MP0002098_abnormal_vibrissa_morphology | 0.47925176 |
130 | MP0005448_abnormal_energy_balance | 0.45983240 |
131 | MP0000377_abnormal_hair_follicle | 0.45893374 |
132 | MP0001243_abnormal_dermal_layer | 0.45880780 |
133 | MP0006035_abnormal_mitochondrial_morpho | 0.44993659 |
134 | MP0000566_synostosis | 0.44186194 |
135 | MP0005275_abnormal_skin_tensile | 0.43831971 |
136 | MP0009379_abnormal_foot_pigmentation | 0.42222289 |
137 | MP0005248_abnormal_Harderian_gland | 0.42008647 |
138 | MP0008874_decreased_physiological_sensi | 0.41622376 |
139 | MP0002136_abnormal_kidney_physiology | 0.41083914 |
140 | MP0005464_abnormal_platelet_physiology | 0.40672766 |
141 | MP0010771_integument_phenotype | 0.40319223 |
142 | MP0003075_altered_response_to | 0.40107767 |
143 | MP0002928_abnormal_bile_duct | 0.39440018 |
144 | MP0004947_skin_inflammation | 0.38977344 |
145 | MP0000467_abnormal_esophagus_morphology | 0.38061608 |
146 | MP0003724_increased_susceptibility_to | 0.37688134 |
147 | MP0001881_abnormal_mammary_gland | 0.37230898 |
148 | MP0003436_decreased_susceptibility_to | 0.37160233 |
149 | MP0002822_catalepsy | 0.37051510 |
150 | MP0002132_abnormal_respiratory_system | 0.36000543 |
151 | MP0005646_abnormal_pituitary_gland | 0.34569002 |
152 | MP0003953_abnormal_hormone_level | 0.34253589 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Intrahepatic cholestasis (HP:0001406) | 7.45423465 |
2 | Deep venous thrombosis (HP:0002625) | 7.35029538 |
3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.18831946 |
4 | Prolonged partial thromboplastin time (HP:0003645) | 6.64832148 |
5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.61838377 |
6 | Xanthomatosis (HP:0000991) | 6.59326892 |
7 | Hypobetalipoproteinemia (HP:0003563) | 6.41055118 |
8 | Hyperlipoproteinemia (HP:0010980) | 5.99704858 |
9 | Increased circulating renin level (HP:0000848) | 5.50056503 |
10 | Complement deficiency (HP:0004431) | 5.22662254 |
11 | Hypolipoproteinemia (HP:0010981) | 5.02905914 |
12 | Joint hemorrhage (HP:0005261) | 4.73565821 |
13 | Epidermoid cyst (HP:0200040) | 4.60475702 |
14 | Hypoalphalipoproteinemia (HP:0003233) | 4.59677773 |
15 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.58560478 |
16 | Hyperammonemia (HP:0001987) | 4.52193356 |
17 | Hyperglycinemia (HP:0002154) | 4.39312624 |
18 | Hypokalemic alkalosis (HP:0001949) | 4.36953580 |
19 | Metabolic alkalosis (HP:0200114) | 4.35139022 |
20 | Abnormality of the common coagulation pathway (HP:0010990) | 4.32346998 |
21 | Abnormality of methionine metabolism (HP:0010901) | 4.23350839 |
22 | Ketosis (HP:0001946) | 4.15798289 |
23 | Fat malabsorption (HP:0002630) | 4.15557625 |
24 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.14508595 |
25 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.08514412 |
26 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.07729325 |
27 | Hyperglycinuria (HP:0003108) | 3.98439847 |
28 | Abnormality of glycine metabolism (HP:0010895) | 3.94343620 |
29 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.94343620 |
30 | Abnormality of complement system (HP:0005339) | 3.87218757 |
31 | Hypoglycemic coma (HP:0001325) | 3.77571188 |
32 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.71579802 |
33 | Conjugated hyperbilirubinemia (HP:0002908) | 3.71485386 |
34 | Hypercholesterolemia (HP:0003124) | 3.66903228 |
35 | Abnormality of the intrinsic pathway (HP:0010989) | 3.60357570 |
36 | Hyperactive renin-angiotensin system (HP:0000841) | 3.32650696 |
37 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.28285992 |
38 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.28219527 |
39 | Hypomagnesemia (HP:0002917) | 3.26606672 |
40 | Hyperbilirubinemia (HP:0002904) | 3.25562842 |
41 | Delayed CNS myelination (HP:0002188) | 3.15802998 |
42 | Steatorrhea (HP:0002570) | 3.14991652 |
43 | Hyperaldosteronism (HP:0000859) | 3.08158335 |
44 | Ketoacidosis (HP:0001993) | 2.99951107 |
45 | Action tremor (HP:0002345) | 2.98432039 |
46 | Abnormality of nail color (HP:0100643) | 2.97495803 |
47 | Renal salt wasting (HP:0000127) | 2.96093944 |
48 | Abnormality of nucleobase metabolism (HP:0010932) | 2.93744067 |
49 | Abnormality of serum amino acid levels (HP:0003112) | 2.91645982 |
50 | Myocardial infarction (HP:0001658) | 2.88566219 |
51 | Hepatocellular carcinoma (HP:0001402) | 2.88057067 |
52 | Alopecia of scalp (HP:0002293) | 2.80607972 |
53 | Spontaneous abortion (HP:0005268) | 2.77643611 |
54 | Hypochromic microcytic anemia (HP:0004840) | 2.76014201 |
55 | Metabolic acidosis (HP:0001942) | 2.70864317 |
56 | Split foot (HP:0001839) | 2.66916219 |
57 | Polyuria (HP:0000103) | 2.64516731 |
58 | Systemic lupus erythematosus (HP:0002725) | 2.63791035 |
59 | White forelock (HP:0002211) | 2.63613097 |
60 | Abnormal urine output (HP:0012590) | 2.62712951 |
61 | Skin nodule (HP:0200036) | 2.60087132 |
62 | Polyphagia (HP:0002591) | 2.59685886 |
63 | Vascular calcification (HP:0004934) | 2.59613407 |
64 | Hyperphosphaturia (HP:0003109) | 2.59450261 |
65 | Abnormality of magnesium homeostasis (HP:0004921) | 2.59013774 |
66 | Abnormality of purine metabolism (HP:0004352) | 2.54826200 |
67 | Dicarboxylic aciduria (HP:0003215) | 2.52412141 |
68 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.52412141 |
69 | Lethargy (HP:0001254) | 2.49099757 |
70 | Patchy hypopigmentation of hair (HP:0011365) | 2.47056797 |
71 | Acanthocytosis (HP:0001927) | 2.45944940 |
72 | Hypoglycemic seizures (HP:0002173) | 2.44460424 |
73 | Neurofibrillary tangles (HP:0002185) | 2.43119241 |
74 | Blue irides (HP:0000635) | 2.39621420 |
75 | Amyloidosis (HP:0011034) | 2.37000328 |
76 | Neonatal onset (HP:0003623) | 2.34769447 |
77 | Palmoplantar hyperkeratosis (HP:0000972) | 2.34730727 |
78 | Glomerulonephritis (HP:0000099) | 2.34571902 |
79 | Abnormality of renal excretion (HP:0011036) | 2.33838278 |
80 | Abnormal gallbladder morphology (HP:0012437) | 2.33436680 |
81 | Spastic diplegia (HP:0001264) | 2.33347391 |
82 | Abnormal eating behavior (HP:0100738) | 2.30457560 |
83 | Cerebral edema (HP:0002181) | 2.30141135 |
84 | Mitral stenosis (HP:0001718) | 2.29471935 |
85 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.28784874 |
86 | Cardiovascular calcification (HP:0011915) | 2.28492713 |
87 | Abnormal drinking behavior (HP:0030082) | 2.25808680 |
88 | Polydipsia (HP:0001959) | 2.25808680 |
89 | Cholelithiasis (HP:0001081) | 2.25697014 |
90 | Irritability (HP:0000737) | 2.25039662 |
91 | Malnutrition (HP:0004395) | 2.24955415 |
92 | Abnormality of renin-angiotensin system (HP:0000847) | 2.23586659 |
93 | Abnormal gallbladder physiology (HP:0012438) | 2.23483858 |
94 | Cholecystitis (HP:0001082) | 2.23483858 |
95 | Abnormality of secondary sexual hair (HP:0009888) | 2.21085182 |
96 | Abnormality of the axillary hair (HP:0100134) | 2.21085182 |
97 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.20865841 |
98 | Hypokalemia (HP:0002900) | 2.20478508 |
99 | Aplasia involving bones of the extremities (HP:0009825) | 2.20304815 |
100 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.20304815 |
101 | Aplasia of the phalanges of the hand (HP:0009802) | 2.20304815 |
102 | Gout (HP:0001997) | 2.20012530 |
103 | Bifid scrotum (HP:0000048) | 2.19264710 |
104 | Plantar hyperkeratosis (HP:0007556) | 2.17618507 |
105 | Palmar hyperkeratosis (HP:0010765) | 2.13343919 |
106 | Osteomalacia (HP:0002749) | 2.11389993 |
107 | Proximal tubulopathy (HP:0000114) | 2.11021603 |
108 | Myokymia (HP:0002411) | 2.10792702 |
109 | Menorrhagia (HP:0000132) | 2.09742212 |
110 | Pancreatitis (HP:0001733) | 2.09091631 |
111 | Intention tremor (HP:0002080) | 2.08764031 |
112 | Gingival bleeding (HP:0000225) | 2.08421765 |
113 | Abnormality of urine glucose concentration (HP:0011016) | 2.08049169 |
114 | Glycosuria (HP:0003076) | 2.08049169 |
115 | Atrioventricular block (HP:0001678) | 2.07626384 |
116 | Abnormality of chloride homeostasis (HP:0011422) | 2.06725536 |
117 | Brushfield spots (HP:0001088) | 2.06243700 |
118 | Esophageal varix (HP:0002040) | 2.05993827 |
119 | Megalencephaly (HP:0001355) | 2.05810665 |
120 | Rickets (HP:0002748) | 2.05285360 |
121 | Sensorimotor neuropathy (HP:0007141) | 2.03941734 |
122 | Late onset (HP:0003584) | 2.03612891 |
123 | Hypotrichosis (HP:0001006) | 2.02685065 |
124 | Enlarged kidneys (HP:0000105) | 2.01272267 |
125 | Abnormal urine phosphate concentration (HP:0012599) | 2.00578387 |
126 | Generalized aminoaciduria (HP:0002909) | 1.99776319 |
127 | Erythroderma (HP:0001019) | 1.98099882 |
128 | Hypophosphatemic rickets (HP:0004912) | 1.97932887 |
129 | Vomiting (HP:0002013) | 1.96944131 |
130 | Hemiparesis (HP:0001269) | 1.93365296 |
131 | Thrombophlebitis (HP:0004418) | 1.92777368 |
132 | Erythema (HP:0010783) | 1.91950079 |
133 | Opisthotonus (HP:0002179) | 1.89930757 |
134 | Abnormality of the gallbladder (HP:0005264) | 1.87431292 |
135 | Hydroxyprolinuria (HP:0003080) | 1.86617587 |
136 | Abnormality of proline metabolism (HP:0010907) | 1.86617587 |
137 | Renal cortical cysts (HP:0000803) | 1.86532550 |
138 | Poikilocytosis (HP:0004447) | 1.86367750 |
139 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.85744518 |
140 | Onycholysis (HP:0001806) | 1.82926695 |
141 | Hemorrhage of the eye (HP:0011885) | 1.81465449 |
142 | Abnormal cartilage morphology (HP:0002763) | 1.78077768 |
143 | Parakeratosis (HP:0001036) | 1.77242766 |
144 | Potter facies (HP:0002009) | 1.77196928 |
145 | Facial shape deformation (HP:0011334) | 1.77196928 |
146 | Paraparesis (HP:0002385) | 1.76586760 |
147 | Alkalosis (HP:0001948) | 1.76222092 |
148 | Abnormality of vitamin metabolism (HP:0100508) | 1.75677054 |
149 | Nephritis (HP:0000123) | 1.74546556 |
150 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.74265300 |
151 | Elevated hepatic transaminases (HP:0002910) | 1.73698433 |
152 | Spastic paraparesis (HP:0002313) | 1.71736061 |
153 | Hypertriglyceridemia (HP:0002155) | 1.70745822 |
154 | Hyperglycemia (HP:0003074) | 1.70345633 |
155 | Abnormality of iron homeostasis (HP:0011031) | 1.70314902 |
156 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.67247899 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BCKDK | 6.44846897 |
2 | SIK1 | 4.67966490 |
3 | NTRK2 | 4.52964299 |
4 | FGFR4 | 4.37366871 |
5 | WNK3 | 4.23503080 |
6 | ERN1 | 4.07336034 |
7 | CASK | 3.57402318 |
8 | MST1R | 3.53715369 |
9 | NTRK3 | 2.99060763 |
10 | MARK1 | 2.90455589 |
11 | INSRR | 2.81463449 |
12 | ERBB4 | 2.75777580 |
13 | OXSR1 | 2.69444347 |
14 | TAOK3 | 2.43431701 |
15 | NTRK1 | 2.23373982 |
16 | MAP2K4 | 2.18160763 |
17 | SGK223 | 2.06526170 |
18 | SGK494 | 2.06526170 |
19 | PIK3CG | 1.99236608 |
20 | FGFR2 | 1.96367898 |
21 | MAPK15 | 1.82560996 |
22 | TYK2 | 1.81377418 |
23 | BCR | 1.73029811 |
24 | MAPK11 | 1.72845463 |
25 | MAP3K3 | 1.70658561 |
26 | LATS1 | 1.68543347 |
27 | MAPK12 | 1.58819085 |
28 | PKN2 | 1.57906685 |
29 | TNIK | 1.55840033 |
30 | PTK6 | 1.52924580 |
31 | FRK | 1.45800062 |
32 | STK24 | 1.43657991 |
33 | FLT3 | 1.41696189 |
34 | ROCK2 | 1.41073768 |
35 | PNCK | 1.36159240 |
36 | MAPK7 | 1.33598063 |
37 | ABL2 | 1.32825706 |
38 | MAP3K4 | 1.31221784 |
39 | PAK6 | 1.31000095 |
40 | TRIB3 | 1.29357285 |
41 | CDK6 | 1.29231684 |
42 | MAP3K12 | 1.25578007 |
43 | MAP3K14 | 1.25396939 |
44 | MET | 1.24369905 |
45 | STK39 | 1.24025211 |
46 | GRK1 | 1.22830548 |
47 | DAPK2 | 1.22326085 |
48 | JAK2 | 1.21937485 |
49 | ARAF | 1.19783865 |
50 | MAP3K2 | 1.17198343 |
51 | MAPK4 | 1.13925989 |
52 | PRKAA2 | 1.12604990 |
53 | BMPR1B | 1.12136825 |
54 | NEK9 | 1.10530076 |
55 | ERBB3 | 1.09510643 |
56 | CSNK1G2 | 1.05323813 |
57 | MAP3K7 | 1.03791470 |
58 | IRAK3 | 1.01137049 |
59 | PHKG2 | 0.99390002 |
60 | PHKG1 | 0.99390002 |
61 | CAMK2B | 0.99237173 |
62 | WNK4 | 0.99036802 |
63 | PINK1 | 0.98648472 |
64 | ERBB2 | 0.97633335 |
65 | PRKD3 | 0.97178099 |
66 | LMTK2 | 0.94333987 |
67 | UHMK1 | 0.94317058 |
68 | JAK1 | 0.94051322 |
69 | KDR | 0.92639991 |
70 | MINK1 | 0.90847810 |
71 | TBK1 | 0.89976696 |
72 | CDK5 | 0.85701731 |
73 | PRKCZ | 0.82994077 |
74 | KSR2 | 0.82662731 |
75 | SGK1 | 0.82485406 |
76 | MOS | 0.81780375 |
77 | MAP4K2 | 0.81620619 |
78 | MAP2K7 | 0.80807655 |
79 | DYRK1B | 0.80648146 |
80 | CAMK2D | 0.80023481 |
81 | MAP2K3 | 0.77826460 |
82 | CAMK2A | 0.76920897 |
83 | EPHA3 | 0.76617881 |
84 | FER | 0.76253823 |
85 | MAP2K6 | 0.76102654 |
86 | BMPR2 | 0.75827590 |
87 | ROCK1 | 0.75027579 |
88 | MAPKAPK3 | 0.74394950 |
89 | PRKACG | 0.73978602 |
90 | FGFR3 | 0.73433716 |
91 | MAPK13 | 0.73423807 |
92 | PRKCG | 0.73408064 |
93 | GRK6 | 0.72524465 |
94 | PIM2 | 0.71555884 |
95 | FGFR1 | 0.70576255 |
96 | TGFBR2 | 0.70561048 |
97 | STK38L | 0.69183769 |
98 | GSK3A | 0.69159702 |
99 | PRKCE | 0.68390494 |
100 | MAP3K10 | 0.67339097 |
101 | TIE1 | 0.64676657 |
102 | CAMK2G | 0.64667477 |
103 | PIK3CA | 0.64581522 |
104 | TYRO3 | 0.62540492 |
105 | IGF1R | 0.60523512 |
106 | MAP3K11 | 0.59283895 |
107 | CSNK1A1 | 0.58563332 |
108 | PTK2 | 0.57101235 |
109 | EPHB1 | 0.56874516 |
110 | IKBKE | 0.56375215 |
111 | CSK | 0.56305035 |
112 | PRKAA1 | 0.55805018 |
113 | CAMK1D | 0.55682502 |
114 | EPHA4 | 0.55112598 |
115 | CSNK1A1L | 0.54558551 |
116 | MAPK10 | 0.53342595 |
117 | CSNK1G3 | 0.52139221 |
118 | EPHB2 | 0.51366983 |
119 | PRKCQ | 0.51062906 |
120 | MAP2K1 | 0.51043499 |
121 | PLK2 | 0.50784156 |
122 | WEE1 | 0.45536258 |
123 | PKN1 | 0.45436443 |
124 | SRC | 0.44742373 |
125 | PDPK1 | 0.42194307 |
126 | MAP3K1 | 0.42170775 |
127 | PDGFRB | 0.41750821 |
128 | CDK4 | 0.40579272 |
129 | RPS6KA3 | 0.38804801 |
130 | PBK | 0.37918160 |
131 | DYRK1A | 0.37357440 |
132 | CAMKK1 | 0.37261068 |
133 | PRKG1 | 0.37246427 |
134 | SGK3 | 0.37104221 |
135 | PRKCA | 0.36732820 |
136 | MAP3K5 | 0.36564629 |
137 | RIPK1 | 0.36476119 |
138 | NEK6 | 0.35105193 |
139 | EPHA2 | 0.33823603 |
140 | CSF1R | 0.33822119 |
141 | TAOK2 | 0.33102607 |
142 | IRAK2 | 0.31864647 |
143 | PAK3 | 0.31064369 |
144 | EGFR | 0.30129042 |
145 | MAP2K2 | 0.29892741 |
146 | MAP3K6 | 0.28970548 |
147 | SGK2 | 0.28809750 |
148 | RET | 0.28136471 |
149 | MAPK3 | 0.27795440 |
150 | CSNK1G1 | 0.27229250 |
151 | ABL1 | 0.26970036 |
152 | IRAK1 | 0.26750579 |
153 | ITK | 0.26626748 |
154 | LRRK2 | 0.26402733 |
155 | PDK1 | 0.24172273 |
156 | LATS2 | 0.24112520 |
157 | PRKACA | 0.22259224 |
158 | BMX | 0.20292782 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.56319715 |
2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.48829548 |
3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.33969712 |
4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.20432621 |
5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.99538484 |
6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.75384538 |
7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.68466944 |
8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.65959554 |
9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.52349813 |
10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.50958709 |
11 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.45362693 |
12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.34605553 |
13 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.27554561 |
14 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.23333464 |
15 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.11936993 |
16 | Peroxisome_Homo sapiens_hsa04146 | 2.08128739 |
17 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.06914910 |
18 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.06637739 |
19 | Histidine metabolism_Homo sapiens_hsa00340 | 2.01996485 |
20 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.00215302 |
21 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.90908398 |
22 | Retinol metabolism_Homo sapiens_hsa00830 | 1.89184470 |
23 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.88633931 |
24 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.83532235 |
25 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.80094688 |
26 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.75295911 |
27 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.74578371 |
28 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.72483428 |
29 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.71666158 |
30 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.65160938 |
31 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.64668734 |
32 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.58461647 |
33 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.56499954 |
34 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.52398312 |
35 | Bile secretion_Homo sapiens_hsa04976 | 1.51507781 |
36 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.47303281 |
37 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.40992621 |
38 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.34640155 |
39 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.33658070 |
40 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.31558874 |
41 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.30587956 |
42 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.28250650 |
43 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.24792126 |
44 | ABC transporters_Homo sapiens_hsa02010 | 1.22652303 |
45 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.22128214 |
46 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.19582005 |
47 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.17099920 |
48 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.13483778 |
49 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.08022382 |
50 | Carbon metabolism_Homo sapiens_hsa01200 | 1.02880662 |
51 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.95728523 |
52 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.94593292 |
53 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.93807233 |
54 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.92874703 |
55 | Sulfur relay system_Homo sapiens_hsa04122 | 0.91433445 |
56 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.88989426 |
57 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.85262236 |
58 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.81890021 |
59 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.69756528 |
60 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.68088699 |
61 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.67197576 |
62 | * Lysine degradation_Homo sapiens_hsa00310 | 0.66803116 |
63 | GABAergic synapse_Homo sapiens_hsa04727 | 0.61973726 |
64 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.61441425 |
65 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.61126244 |
66 | Nicotine addiction_Homo sapiens_hsa05033 | 0.51201716 |
67 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.50858215 |
68 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.50488735 |
69 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.48299964 |
70 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.46764018 |
71 | Metabolic pathways_Homo sapiens_hsa01100 | 0.46686332 |
72 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.43037069 |
73 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.42490682 |
74 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.41089492 |
75 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.39815960 |
76 | Circadian entrainment_Homo sapiens_hsa04713 | 0.39630785 |
77 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.37565419 |
78 | Prion diseases_Homo sapiens_hsa05020 | 0.31242301 |
79 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.29976405 |
80 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.28762717 |
81 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.27591114 |
82 | Cocaine addiction_Homo sapiens_hsa05030 | 0.24058892 |
83 | Insulin secretion_Homo sapiens_hsa04911 | 0.22993526 |
84 | Insulin resistance_Homo sapiens_hsa04931 | 0.21665004 |
85 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.21653809 |
86 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.21595632 |
87 | Galactose metabolism_Homo sapiens_hsa00052 | 0.20269487 |
88 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.19895895 |
89 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.19841931 |
90 | Morphine addiction_Homo sapiens_hsa05032 | 0.19319941 |
91 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.16447549 |
92 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.15089510 |
93 | Renin secretion_Homo sapiens_hsa04924 | 0.14419998 |
94 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.13210642 |
95 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.08206571 |
96 | Salivary secretion_Homo sapiens_hsa04970 | 0.07698717 |
97 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.06721093 |
98 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.06139481 |
99 | Long-term depression_Homo sapiens_hsa04730 | 0.02878999 |
100 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.01846466 |
101 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.01826667 |
102 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.01204865 |
103 | Long-term potentiation_Homo sapiens_hsa04720 | 0.00928673 |
104 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.00223766 |
105 | Bladder cancer_Homo sapiens_hsa05219 | -0.2437841 |
106 | Circadian rhythm_Homo sapiens_hsa04710 | -0.2264471 |
107 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.2024635 |
108 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.2020548 |
109 | Mineral absorption_Homo sapiens_hsa04978 | -0.1962911 |
110 | Amoebiasis_Homo sapiens_hsa05146 | -0.1939884 |
111 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1938417 |
112 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1933162 |
113 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1930848 |
114 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1871247 |
115 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.1771458 |
116 | Hepatitis C_Homo sapiens_hsa05160 | -0.1745079 |
117 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1525466 |
118 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1275495 |
119 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1241613 |
120 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1226299 |
121 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.1123304 |
122 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0903129 |
123 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0494973 |
124 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0107241 |